Literature DB >> 14630614

Effect of acute lung injury on structure and function of pulmonary surfactant films.

Amiya K Panda1, Kaushik Nag, Robert R Harbottle, Karina Rodriguez-Capote, Ruud A W Veldhuizen, Nils O Petersen, Fred Possmayer.   

Abstract

The structural and functional alterations in pulmonary surfactant that occur during acute lung injury were studied using rat lung surfactant large aggregates (LA) isolated from normal nonventilated lungs (N), and from standard ventilated (V) and injuriously ventilated (IV) excised lungs. N lungs inflated significantly better than IV lungs, with V lungs intermediate. Although IV LA phosphatidylcholine levels were unchanged, cholesterol and protein were elevated. V LA exhibited PC/cholesterol and PC/protein ratios intermediate between N and IV. In contrast to total cholesterol and protein levels, these ratios were not significantly different from IV LA. N and V LA, but not IV LA, adsorbed rapidly and were able to generate surface pressures (pi) near 70 mN/m during surface area reduction at 37 degrees C on a captive bubble tensiometer. Langmuir-Wilhelmy surface balance studies at 23 degrees C showed N LA films consistently attained pi approaching 70 mN/m during ten compression-expansion cycles. IV films were less effective and failed to achieve high pi consistently after the sixth cycle. V films were intermediate. Epifluorescence studies revealed compression of adsorbed N LA films formed well-defined liquid-condensed (LC) domains, but fewer, smaller domains were observed with IV films and, to a lesser extent, V films. Atomic force microscopy on Langmuir-Blodgett N films transferred at pi = 30 mN/m showed high, well-defined LC domains. IV films showed thinner, intermediate height, possibly fluid domains, which contain large numbers of small higher domains with heights corresponding to LC domains. V films were intermediate. We conclude that acute lung injury induced by hyperventilation, and to a lesser extent standard ventilation, of excised lungs alters surfactant surface activity and the ability of natural surfactant to form surface structures at the air-water interface.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630614     DOI: 10.1165/rcmb.2003-0279OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  11 in total

1.  Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants.

Authors:  Pierre Tissières; Patrick Myers; Maurice Beghetti; Michel Berner; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

2.  An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.

Authors:  Zoya Leonenko; Simardeep Gill; Svetlana Baoukina; Luca Monticelli; Jana Doehner; Lasantha Gunasekara; Florian Felderer; Mathias Rodenstein; Lukas M Eng; Matthias Amrein
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

3.  The molecular mechanism of monolayer-bilayer transformations of lung surfactant from molecular dynamics simulations.

Authors:  Svetlana Baoukina; Luca Monticelli; Matthias Amrein; D Peter Tieleman
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  The mechanism of collapse of heterogeneous lipid monolayers.

Authors:  Svetlana Baoukina; Dmitri Rozmanov; Eduardo Mendez-Villuendas; D Peter Tieleman
Journal:  Biophys J       Date:  2014-09-02       Impact factor: 4.033

5.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

6.  Probing perturbation of bovine lung surfactant extracts by albumin using DSC and 2H-NMR.

Authors:  Kaushik Nag; Kevin M W Keough; Michael R Morrow
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

7.  Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Authors:  Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Thorsten Colaris; Bhola Dahal; Dieter Walmrath; Heinz Harbach; Jochen Wilhelm; Werner Seeger; Reinhold Schmidt; Andreas Guenther
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

8.  Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.

Authors:  Yi Y Zuo; Seyed M Tadayyon; Eleonora Keating; Lin Zhao; Ruud A W Veldhuizen; Nils O Petersen; Matthias W Amrein; Fred Possmayer
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

9.  Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.

Authors:  Gilman B Allen; Mary E Cloutier; Yuna C Larrabee; Konstantin Tetenev; Stephen T Smiley; Jason H T Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-05       Impact factor: 5.464

10.  Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant.

Authors:  Eleonora Keating; Luna Rahman; James Francis; Anne Petersen; Fred Possmayer; Ruud Veldhuizen; Nils O Petersen
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.